BackTable / Tumor Board / Contributor

Dr. Sarah Psutka
Urologic Oncologist
Dr. Sarah Psutka is a urologic oncologist and associate professor at University of Washington in Seattle.
Listen to Dr. Sarah Psutka on the BackTable Podcast
The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Sarah Psutka and get practical advice on how to build your practice by listening to the BackTable Podcast.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
About Dr. Sarah Psutka
Dr. Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital. She completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters’ in Clinical and Translational Science.
Dr. Psutka’s clinical efforts focus on minimally-invasive and complex open urologic oncology, with a particular interest in advanced bladder, kidney, and testis cancer. In addition to her practice at the University of Washington main campus, she leads the urologic oncology program at Harborview Medical Center and is the Associate Program Director of the UW Society of Urologic Oncology Fellowship Program.
Dr. Psutka’s research focuses on the study and development of personalized, comprehensive risk stratification measures in patients with advanced urologic malignancies. She leads research studying the integration of principles of aging research, comprehensive geriatric assessments, body composition, and psychometric capital assessments in patients with advanced GU malignancies with a focus on patient-reported outcomes and development of prehabilitation interventions. She currently leads multiple clinical trials in bladder and kidney cancer. Her research has been funded by the National Institute of Aging (2022-2024 GEMSSTAR award), and the Bladder Cancer Advocacy Network, and she was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award. She is a member of the Board of Directors of the Society of Urologic Oncology, the SUO Clinical Trials Consortium (Kidney), The SUO Fellowship Committee and Education Committee, the SWOG Clinical Trials Survivorship Committee, and the Bladder Cancer Advocacy Network Steering Committee. She was a co-founder of the Society of Women in Urologic Oncology. Dr. Psutka is the Senior Editor for the Urologic Oncology Section of the AUA Core Curriculum and is an Associate Editor for European Urology.
Learn more by visiting Dr. Sarah Psutka's practice:
Podcasts Featuring Dr. Sarah Psutka
Urology Episode #271
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for invasive cystoscopies? In part five of the 2025 BackTable NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam engages in an insightful discussion with Dr. Sarah Psutka from the University of Washington and Dr. Katie Murray from NYU about the complexities and potential benefits of using biomarkers in non-muscle invasive bladder cancer (NMIBC).
Tumor Board Episode #31
One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder and the ureter? In the final episode of the 2025 NMIBC Creator Weekend™ series, Dr. Vignesh Packiam, Dr. Mark Tyson and Dr. Sarah Psutka share how they approach complex bladder cancer cases with upper tract involvement.
Tumor Board Episode #30
When standard therapy fails, it does not have to be the end of the road for high-risk bladder cancer patients. Modern treatments, biomarkers, and clinical studies have opened up new avenues for treating recurrent non-muscle invasive bladder cancer (NMIBC). The penultimate episode of the 2025 NMIBC Creator Weekend™ series features urologic oncologists Dr. Vignesh Packiam, Dr. Mark Tyson, and Dr. Sarah Psutka discussing how they navigate complex bladder cancer scenarios.
Tumor Board Episode #28
As new genetic and AI-powered tools emerge for bladder cancer screening, are we getting closer to reducing the need for invasive cystoscopies? In part five of the 2025 BackTable NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam engages in an insightful discussion with Dr. Sarah Psutka from the University of Washington and Dr. Katie Murray from NYU about the complexities and potential benefits of using biomarkers in non-muscle invasive bladder cancer (NMIBC).
Get in touch!
We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.













